EXHIBIT 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Immunome, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

Dated: February 4, 2025

Immunome Aggregator, LP


By:

Enavate Sciences GP, LLC

its

General Partner


By:

/s/ James P. Boylan

Name: James P. Boylan

Title: Manager


Enavate Sciences GP, LLC


By:

/s/ James P. Boylan

Name: James P. Boylan

Title: Manager




Immunome (NASDAQ:IMNM)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Immunome.
Immunome (NASDAQ:IMNM)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Immunome.